Abstract:Matrix metalloproteinase-7 (MMP-7) (also known as matrilysin-1) is secreted as a proenzyme (proMMP-7) and plays a key role in the degradation of various extracellular matrix (ECM) and non-ECM molecules after activation. To identify the binding proteins related to proMMP-7 activation, a human lung cDNA library was screened by yeast two-hybrid system using proMMP-7 as bait. We identified a candidate molecule CD151, which is a member of the transmembrane 4 superfamily. Complex formation of proMMP-7 with CD151 was… Show more
“…These include CD44 heparan sulfate proteoglycan (HSPG), cholesterol sulfate, and CD151. [18][19][20] Cholesterol sulfate is a component of lipid raft and CD151 is a transmembrane 4 superfamily protein that appears in a detergent-insoluble lipid-containing microdomain. To learn the possible docking mechanism of MMP-7, the behavior of the membrane-associated MMP-7(Asp-137) variant was analyzed in the presence of detergent.…”
Section: Resultsmentioning
confidence: 99%
“…19 In contrast, CD151 anchors latent proMMP-7 onto the cell surface, but its affinity to interact with the active form of MMP-7 is relatively low. 20 Therefore, we hypothesized that association of the pro-form of MMP-7(Asp-137) variant to CD151 at the cell surface provides the opportunity for MMP-7 activation. The hypothesis was first examined by confocal microscopy to learn the distribution patterns of MMP-7 and CD151 in HSCs under nonpermeabilized conditions.…”
Liver cirrhosis is characterized by progressive accumulation of extracellular matrix following chronic liver injuries. In the extracellular space, the constant turnover of liver matrix is regulated by the matrix metalloproteinase (MMP) class of enzyme. To assess whether genetic variations in MMP would result in diversity of liver cirrhosis, a case-control study of 320 patients with hepatocellular carcinoma, with or without cirrhosis, was conducted. Ten single-nucleotide polymorphism markers from four potential fibrosis-associated genes were selected for genotyping. Among these genes, a nonsynonymous single-nucleotide polymorphism which generates the variation of Gly-137 and Asp-137 in the MMP-7 gene was found to be strongly associated with the development of liver cirrhosis. In contrast to MMP-7(Gly-137) that predominantly secretes out into the cell culture medium, the cirrhosis-associated MMP-7(Asp-137) variant is preferentially localized on the extracellular membranes where it exerts its proteolytic activity on pericellular substrates. Functional analysis demonstrated an increased ability of the MMP-7(Asp-137) variant to associate with the cell surface CD151 molecule. In wound-healing and Boyden chamber assays, cell motility was specifically enhanced with the expression of MMP-7(Asp-137) as compared to the cells expressing MMP-7(Gly-137). These results demonstrate that the MMP-7(Asp-137) variant confers a gain-of-function phenotype for MMP-7. Conclusion: We have identified a novel genetic association of MMP-7(Asp-137) variant with liver cirrhosis in patients with hepatocellular carcinoma. Whether the MMP-7 variant can be a new marker for liver cirrhosis will be further studied.
“…These include CD44 heparan sulfate proteoglycan (HSPG), cholesterol sulfate, and CD151. [18][19][20] Cholesterol sulfate is a component of lipid raft and CD151 is a transmembrane 4 superfamily protein that appears in a detergent-insoluble lipid-containing microdomain. To learn the possible docking mechanism of MMP-7, the behavior of the membrane-associated MMP-7(Asp-137) variant was analyzed in the presence of detergent.…”
Section: Resultsmentioning
confidence: 99%
“…19 In contrast, CD151 anchors latent proMMP-7 onto the cell surface, but its affinity to interact with the active form of MMP-7 is relatively low. 20 Therefore, we hypothesized that association of the pro-form of MMP-7(Asp-137) variant to CD151 at the cell surface provides the opportunity for MMP-7 activation. The hypothesis was first examined by confocal microscopy to learn the distribution patterns of MMP-7 and CD151 in HSCs under nonpermeabilized conditions.…”
Liver cirrhosis is characterized by progressive accumulation of extracellular matrix following chronic liver injuries. In the extracellular space, the constant turnover of liver matrix is regulated by the matrix metalloproteinase (MMP) class of enzyme. To assess whether genetic variations in MMP would result in diversity of liver cirrhosis, a case-control study of 320 patients with hepatocellular carcinoma, with or without cirrhosis, was conducted. Ten single-nucleotide polymorphism markers from four potential fibrosis-associated genes were selected for genotyping. Among these genes, a nonsynonymous single-nucleotide polymorphism which generates the variation of Gly-137 and Asp-137 in the MMP-7 gene was found to be strongly associated with the development of liver cirrhosis. In contrast to MMP-7(Gly-137) that predominantly secretes out into the cell culture medium, the cirrhosis-associated MMP-7(Asp-137) variant is preferentially localized on the extracellular membranes where it exerts its proteolytic activity on pericellular substrates. Functional analysis demonstrated an increased ability of the MMP-7(Asp-137) variant to associate with the cell surface CD151 molecule. In wound-healing and Boyden chamber assays, cell motility was specifically enhanced with the expression of MMP-7(Asp-137) as compared to the cells expressing MMP-7(Gly-137). These results demonstrate that the MMP-7(Asp-137) variant confers a gain-of-function phenotype for MMP-7. Conclusion: We have identified a novel genetic association of MMP-7(Asp-137) variant with liver cirrhosis in patients with hepatocellular carcinoma. Whether the MMP-7 variant can be a new marker for liver cirrhosis will be further studied.
“…Rather, proteinases, such as MMPs, would likely be anchored to the cell membrane, thereby maintaining a locally high enzyme concentration and targeting their catalytic activity to specific substrates within the pericellular space. In addition to the membrane-bound MMPs, several examples of specific cell-MMP interactions have been reported, such as the binding of MMP-2 to the α v β 3 integrin (Brooks et al, 1996), MMP-1 to the α 2 β 1 integrin Stricker et al, 2001), MMP-9 to CD44 (Yu and Stamenkovic, 2000), and MMP-7 to surface proteoglycans (Yu and Woessner, 2000;Yu et al, 2002), cholesterol (Yamamoto et al, 2006), and CD151 (Shiomi et al, 2005). As suggested for CD44 (Yu and Stamenkovic, 2000) and the α 2 β 1 integrin ), these membrane anchors may act as accessory factors that mediate both pro-enzyme activation and binding of both substrate and proteinase, thereby increasing the probability of proteolysis (Fig.…”
Section: Compartmentalizationmentioning
confidence: 99%
“…3). For example, Shiomi et al (2005) reported that CD151, a tetraspanin, binds and activates proMMP-7. The authors speculate that CD151 causes a conformational change in proMMP-7, thus facilitating a spontaneous activation of proMMP-7 on a pericellular level.…”
Section: Compartmentalizationmentioning
confidence: 99%
“…The authors speculate that CD151 causes a conformational change in proMMP-7, thus facilitating a spontaneous activation of proMMP-7 on a pericellular level. Interestingly, activated MMP-7 was only detected in the presence of carboxylmethylated transferrin, a preferred in vitro substrate of MMP-7 (Shiomi et al, 2005). Thus, membrane anchors may function by facilitating the interaction between substrate and proteinase, and in the presence of substrate, the allosteric release of the cysteine switch may be more favored.…”
SummaryAs their name implies, MMPs were first described as proteases that degrade extracellular matrix proteins, such as collagens, elastin, proteoglycans, and laminins. However, studies of MMP function in vivo have revealed that these proteinases act on a variety of extracellular protein substrates, often to activate latent forms of effector proteins, such as antimicrobial peptides and cytokines, or to alter protein function, such as shedding of cell-surface proteins. Because their substrates are diverse, MMPs are involved in variety of homeostatic functions, such as bone remodeling, wound healing, and several aspects of immunity. However, MMPs are also involved in a number of pathological processes, such as tumor progression, fibrosis, chronic inflammation, tissue destruction, and more. A key step in regulating MMP proteolysis is the conversion of the zymogen into an active proteinase. Several proMMPs are activated in the secretion pathway by furin proprotein convertases, but for most the activation mechanisms are largely not known. In this review, we discuss both authentic and potential mechanisms of proMMP activation.
Objective. The proenzyme of matrix metalloproteinase 7 (proMMP-7), which can degrade various extracellular matrix (ECM) and non-ECM molecules after being activated, is overexpressed in osteoarthritic (OA) articular cartilage, but the process of its activation in the cartilage remains unknown. The present study was undertaken to investigate the expression of tetraspanin CD151 in OA cartilage and its involvement in proMMP-7 activation.Methods. The expression of CD151 in articular cartilage was examined by reverse transcriptionpolymerase chain reaction (RT-PCR), real-time PCR, immunohistochemistry, in situ hybridization, and immunoblotting. Chondrocytes were used to study the interaction between CD151 and proMMP-7, and activation of proMMP-7.Results Conclusion. These data demonstrate that CD151 is overexpressed in OA cartilage and suggest that CD151 plays a role in the pericellular activation of proMMP-7, leading to cartilage destruction and/or chondrocyte cloning.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.